Cargando…
Comparative pharmacokinetics of osmotic-controlled and immediate-release Eperisone tablet formulation in healthy human subjects using a sensitive plasma LC-ESI-MS/MS method
To evaluate and compare the pharmacokinetic (PK) characteristics of a newly developed oral osmotically controlled drug delivery system of Eperisone 150 mg tablets with Eperisone immediate release (IR) marketed tablet brand as a reference formulation. It was a single dose, two treatment, two sequence...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7002734/ https://www.ncbi.nlm.nih.gov/pubmed/32024955 http://dx.doi.org/10.1038/s41598-020-58801-1 |
_version_ | 1783494415142092800 |
---|---|
author | Ahmed, Kamran Shoaib, Muhammad Harris Yousuf, Rabia Ismail Siddiqui, Fahad Qazi, Faaiza Iftikhar, Javeria Ahmed, Farrukh Rafiq Nasiri, Muhammad Iqbal |
author_facet | Ahmed, Kamran Shoaib, Muhammad Harris Yousuf, Rabia Ismail Siddiqui, Fahad Qazi, Faaiza Iftikhar, Javeria Ahmed, Farrukh Rafiq Nasiri, Muhammad Iqbal |
author_sort | Ahmed, Kamran |
collection | PubMed |
description | To evaluate and compare the pharmacokinetic (PK) characteristics of a newly developed oral osmotically controlled drug delivery system of Eperisone 150 mg tablets with Eperisone immediate release (IR) marketed tablet brand as a reference formulation. It was a single dose, two treatment, two sequence, randomized, crossover study, involving 12 healthy human subjects. A modified, sensitive LC-ESI-MS/MS method was developed and validated as per FDA guidelines for estimation of Eperisone in plasma using a simple extraction and quick protein precipitation method. Non-compartmental pharmacokinetic model was used for PK analysis. Results were statistically compared using logarithmically transformed data, where p > 0.05 was considered as non-significant with 90% CI limit of 0.8–1.25. The bio-analytical method used for estimating drug plasma concentration was found to be simple, selective, linear, accurate and precise with 0.01 ng/ml as limit of detection. The comparative PK analysis revealed an insignificant difference in AUC(0-∞,) AUC(0-t,) V(z)/F, Cl/F and t(1/2λz), whereas a significant difference in C(max), T(max) and MTTs were found. The relative bioavailability of Eperisone osmotic tablet was 109.7%. The osmotic controlled release drug formulation was found to release Eperisone for an extended period with less inter individual fluctuation in pharmacokinetic variables. |
format | Online Article Text |
id | pubmed-7002734 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-70027342020-02-14 Comparative pharmacokinetics of osmotic-controlled and immediate-release Eperisone tablet formulation in healthy human subjects using a sensitive plasma LC-ESI-MS/MS method Ahmed, Kamran Shoaib, Muhammad Harris Yousuf, Rabia Ismail Siddiqui, Fahad Qazi, Faaiza Iftikhar, Javeria Ahmed, Farrukh Rafiq Nasiri, Muhammad Iqbal Sci Rep Article To evaluate and compare the pharmacokinetic (PK) characteristics of a newly developed oral osmotically controlled drug delivery system of Eperisone 150 mg tablets with Eperisone immediate release (IR) marketed tablet brand as a reference formulation. It was a single dose, two treatment, two sequence, randomized, crossover study, involving 12 healthy human subjects. A modified, sensitive LC-ESI-MS/MS method was developed and validated as per FDA guidelines for estimation of Eperisone in plasma using a simple extraction and quick protein precipitation method. Non-compartmental pharmacokinetic model was used for PK analysis. Results were statistically compared using logarithmically transformed data, where p > 0.05 was considered as non-significant with 90% CI limit of 0.8–1.25. The bio-analytical method used for estimating drug plasma concentration was found to be simple, selective, linear, accurate and precise with 0.01 ng/ml as limit of detection. The comparative PK analysis revealed an insignificant difference in AUC(0-∞,) AUC(0-t,) V(z)/F, Cl/F and t(1/2λz), whereas a significant difference in C(max), T(max) and MTTs were found. The relative bioavailability of Eperisone osmotic tablet was 109.7%. The osmotic controlled release drug formulation was found to release Eperisone for an extended period with less inter individual fluctuation in pharmacokinetic variables. Nature Publishing Group UK 2020-02-05 /pmc/articles/PMC7002734/ /pubmed/32024955 http://dx.doi.org/10.1038/s41598-020-58801-1 Text en © The Author(s) 2020 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Article Ahmed, Kamran Shoaib, Muhammad Harris Yousuf, Rabia Ismail Siddiqui, Fahad Qazi, Faaiza Iftikhar, Javeria Ahmed, Farrukh Rafiq Nasiri, Muhammad Iqbal Comparative pharmacokinetics of osmotic-controlled and immediate-release Eperisone tablet formulation in healthy human subjects using a sensitive plasma LC-ESI-MS/MS method |
title | Comparative pharmacokinetics of osmotic-controlled and immediate-release Eperisone tablet formulation in healthy human subjects using a sensitive plasma LC-ESI-MS/MS method |
title_full | Comparative pharmacokinetics of osmotic-controlled and immediate-release Eperisone tablet formulation in healthy human subjects using a sensitive plasma LC-ESI-MS/MS method |
title_fullStr | Comparative pharmacokinetics of osmotic-controlled and immediate-release Eperisone tablet formulation in healthy human subjects using a sensitive plasma LC-ESI-MS/MS method |
title_full_unstemmed | Comparative pharmacokinetics of osmotic-controlled and immediate-release Eperisone tablet formulation in healthy human subjects using a sensitive plasma LC-ESI-MS/MS method |
title_short | Comparative pharmacokinetics of osmotic-controlled and immediate-release Eperisone tablet formulation in healthy human subjects using a sensitive plasma LC-ESI-MS/MS method |
title_sort | comparative pharmacokinetics of osmotic-controlled and immediate-release eperisone tablet formulation in healthy human subjects using a sensitive plasma lc-esi-ms/ms method |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7002734/ https://www.ncbi.nlm.nih.gov/pubmed/32024955 http://dx.doi.org/10.1038/s41598-020-58801-1 |
work_keys_str_mv | AT ahmedkamran comparativepharmacokineticsofosmoticcontrolledandimmediatereleaseeperisonetabletformulationinhealthyhumansubjectsusingasensitiveplasmalcesimsmsmethod AT shoaibmuhammadharris comparativepharmacokineticsofosmoticcontrolledandimmediatereleaseeperisonetabletformulationinhealthyhumansubjectsusingasensitiveplasmalcesimsmsmethod AT yousufrabiaismail comparativepharmacokineticsofosmoticcontrolledandimmediatereleaseeperisonetabletformulationinhealthyhumansubjectsusingasensitiveplasmalcesimsmsmethod AT siddiquifahad comparativepharmacokineticsofosmoticcontrolledandimmediatereleaseeperisonetabletformulationinhealthyhumansubjectsusingasensitiveplasmalcesimsmsmethod AT qazifaaiza comparativepharmacokineticsofosmoticcontrolledandimmediatereleaseeperisonetabletformulationinhealthyhumansubjectsusingasensitiveplasmalcesimsmsmethod AT iftikharjaveria comparativepharmacokineticsofosmoticcontrolledandimmediatereleaseeperisonetabletformulationinhealthyhumansubjectsusingasensitiveplasmalcesimsmsmethod AT ahmedfarrukhrafiq comparativepharmacokineticsofosmoticcontrolledandimmediatereleaseeperisonetabletformulationinhealthyhumansubjectsusingasensitiveplasmalcesimsmsmethod AT nasirimuhammadiqbal comparativepharmacokineticsofosmoticcontrolledandimmediatereleaseeperisonetabletformulationinhealthyhumansubjectsusingasensitiveplasmalcesimsmsmethod |